Response to the Reviewers MS # 56757i1 Title: “Thymosin β4 increases cardiac cell proliferation, cell engraftment, and the reparability potency of human induced pluripotent stem cells derived cardiomyocytes in a porcine model of acute myocardial infarction” by Tan

Shi Hua Tan,Sze Jie Loo,Yu Gao,Zhong Hao Tao,Li Ping Su,Chen Xu,Sophia L. Zhang,Yong Hui Mu,Ying Hua Cui,Desiree Abdurrachim,Wei,Hsin Wang,Janise Lalic,Kheng Choon Lim,Jun Bu,Ru San Tan,Teck Hock Lee,Jianyi Zhang,Lei Ye

2021-01-01

Abstract:Reviewer 1.2: The authors don’t address and prove the synergistic effect of Tb4 and iPSC-CMs on the improvement of cardiac function through the major revision process. Reply: we thank reviewer’s comment. We do not claim that it is the synergistic effect of Tb4 and iPSC-CMs on the improvement of cardiac function, instead we have demonstrated that co-treatment with Tb4 enhanced the reparative potency of hiPSC-CMs through: 1. Inducing the proliferation of cardiomyocytes and endothelial cells in vitro (Figure 2 and Figures S2A-D, respectively) and in vivo (Figure 6 and Figures S8A&B); 2. Inducing vasculogenesis in infarcted myocardium (Figure 4); 3. Enhancing hiPSC-CM viability (Figure 1) and engraftment (Figure 5A&B); All of these contribute to robust improvements in left ventricular systolic function and infarct size in the hearts of the Tb4 + CM Group. On the contrary, only hiPSC-CM transplantation did not improve vasculogenesis and heart function, induce proliferation of cardiomyocytes and endothelial cells, and reduce infarct size. Thus, these data demonstrate that co-transplantation of Tb4 and hiPSC-CMs enhanced the reparative potency of hiPSC-CMs for treatment of acute MI.